AbstractHIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. However, to date HIV-1 vaccine candidate immunogens have not induced potent and broadly neutralizing antibodies against subtype C primary isolates. We have used a centralized gene strategy to address HIV-1 diversity and generated a group M consensus envelope gene with shortened consensus variable loops (CON-S) for comparative studies with wild-type (WT) Env immunogens. Our results indicate that the consensus HIV-1 group M CON-S Env elicited cross-subtype neutralizing antibodies of similar or greater breadth and titer than the WT Envs tested, indicating the utility of a centralized gene strategy. Our study also shows the feasibility of iterativ...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
One of the challenges facing HIV vaccine development is the diversity of the envelope protein (Env)....
One of the challenges facing HIV vaccine development is the diversity of the envelope protein (Env)....
HIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. However, ...
AbstractHIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. H...
Abstract“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-react...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-reactive T ce...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
Abstract“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-react...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
AbstractImmunogens based on “centralized” (ancestral or consensus) HIV-1 sequences minimize the gene...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
One of the challenges facing HIV vaccine development is the diversity of the envelope protein (Env)....
One of the challenges facing HIV vaccine development is the diversity of the envelope protein (Env)....
HIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. However, ...
AbstractHIV-1 subtype C is the most common HIV-1 group M subtype in Africa and many parts of Asia. H...
Abstract“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-react...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-reactive T ce...
Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field viru...
Abstract“Centralized” (ancestral and consensus) HIV-1 envelope immunogens induce broadly cross-react...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
AbstractImmunogens based on “centralized” (ancestral or consensus) HIV-1 sequences minimize the gene...
The genetic diversity among globally circulating human immunodeficiency virus type 1 (HIV-1) strains...
Genetic variation of human immunodeficiency virus (HIV-1) represents a major obstacle for AIDS vacci...
One of the challenges facing HIV vaccine development is the diversity of the envelope protein (Env)....
One of the challenges facing HIV vaccine development is the diversity of the envelope protein (Env)....